Literature DB >> 19253245

Bacterial contamination of needle points after intravitreal injection.

Martin Nentwich1, Yazmin Yactayo-Miranda, Steffen Weimann, Stephan Froehlich, Armin Wolf, Anselm Kampik, Herminia Mino De Kaspar.   

Abstract

PURPOSE: Evaluation of the magnitude and pattern of bacterial contamination of needle points with conjunctival bacteria during the intravitreal injection. Analysis of the efficacy of preinjection prophylaxis.
METHODS: A total of 550 intravitreal injections were done in 414 patients (n=425 eyes). A total of 289 patients were injected once, while 125 patients received several injections. Before the intravitreal injection in the operation room, the following standard preoperative preparation of the eye-10% povidone iodine scrub on the eyelids, eyelashes, and forehead and irrigation of the conjunctival sac with 1% povidone iodine-was carried out. Immediately after the injection, the needle points were rinsed three times in thioglycolate broth, which was cultured at 35 degrees C for 5 days afterwards. As a negative control, 200 sterile unused needle points were treated the same way.
RESULTS: Only 2 out of 550 (0.36%) needle points were contaminated after intravitreal injection. In sensitivity testing, the isolated Staphylococcus epidermidis and Corynebacterium sp did not show multidrug resistance. All 200 unused needle points proved to be sterile after 5 days of cultivation.
CONCLUSIONS: Contamination of needle points is minimal after iodine irrigation prophylaxis before intravitreal injection. Therefore, we recommend this prophylaxis technique before intravitreal injections. The low incidence of contaminated needle points, however, shows that there still is a risk of bacteria entering into the eye during injection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19253245     DOI: 10.1177/112067210901900215

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

1.  [Bacterial contamination of needles after intravitreal injection in Paraguay].

Authors:  J C Gines; M M Nentwich; A H Peggy Bedoya; P Cibils; A Esteche; F Laspina; M Samudio; N Fariña; H M de Kaspar
Journal:  Ophthalmologe       Date:  2012-08       Impact factor: 1.059

Review 2.  Diabetic retinopathy - ocular complications of diabetes mellitus.

Authors:  Martin M Nentwich; Michael W Ulbig
Journal:  World J Diabetes       Date:  2015-04-15

3.  Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection.

Authors:  Yasushi Ikuno; Miki Sawa; Motokazu Tsujikawa; Fumi Gomi; Naoyuki Maeda; Kohji Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-06-28       Impact factor: 2.447

4.  Impurities in Drug Vials Intended for Intravitreal Medication.

Authors:  Lisa Pohl; Lisa Strudel; Spyridon Dimopoulos; Focke Ziemssen
Journal:  Case Rep Ophthalmol Med       Date:  2020-12-02

5.  Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces.

Authors:  Lyubomyr M Lytvynchuk; Goran Petrovski; Adien Dam; Joep Hiemstra; Tobias Wimmer; Iryna Savytska; Susanne Binder; Knut Stieger
Journal:  Clin Ophthalmol       Date:  2021-02-19

Review 6.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.